<< Back to news of subsidiaries
27/10/2008Stallergenes: Launch of a phase III clinical trial in adults for Oralair® Grasses in the United States - Operating income expected to remain stable in 2009
>> Read more
15/10/20082008 Sales guidance revised upwards: +14%
07/10/2008Stallergenes partners with Catalent and The Medical House for commercialization of adrenaline autoinjector in europe
11/09/2008Stallergenes inaugurales the biggest pharmaceutical allergen production unit in the world
27/08/2008Stallergènes: First half year 2008 - A 19% increase in operating profit and net profit
10/07/2008Stallergènes: Q2 2008 Sales up 18% - 1st half-year sales up 16%
24/06/2008Stallergenes: sublingual desensitisation tablets oralair® grasses approved in Germany
15/04/2008Stallergènes: 2008 1st quarter sales up 15%
12/03/2008Stallergènes: Further profit growth
15/01/2008Stallergènes: 2007 A further year of strong growth: up 16%
13/12/2007STALLERGENES et PROTEIN'EXPERT S.A. enter into a partnership for producing mites recombinant allergens
28/11/2007Stallergènes : Oralair® Grasses: Positive results of VO52.06 paediatric study
11/10/2007Stallergènes: 3rd quarter (Q3) sales up 17% - 9 month cumulative sales up 17%
28/08/2007Stallergènes: 2007 half-year results - Strong business growth
12/07/2007Stallergènes: 2007 1st half-year sales up 17%
14/05/2007Stallergènes and CMC Biopharmaceuticals sign manufacturing agreement for recombinant Bet v1
17/04/2007Stallergènes: 2007 1st quarter sales up 20%
15/03/2007Stallergènes: Increase in operating profit and additional R&D efforts
13/02/2007Stallergènes enters the Netherlands through a joint venture agreement
15/01/2007Stallergènes: 2006 4th quarter sales up 13%
09/01/2007Stallergènes and Paladin Labs sign a partnership for Oralair(TM) in Canada
13/10/2006Stallergènes: 2006 3rd quarter - Sales up 9%
12/09/2006Stallergènes : 1st Half Year 2006 - a 14% increase in sales
12/07/2006Stallergènes: 2006 1st Half Year Group Sales - Group sales up 14%
12/04/2006Stallergènes : 1st quarter 2006 - Strong sales growth of 17%
15/03/2006Stallergènes: 2005 Further strong growth in profit - Oralair study successful
09/03/2006Stallergènes : Positive results of studyrecombinant Bet v1
13/01/20062005 sales: +18% (+15% organic). 2005 4th quarter sales: +14% (+10% organic)
28/11/2005Stallergènes: the positive results of the "grass pollen tablet" study allow the active continuation of its development program.
13/10/2005Stallergènes: 17% increase in 2005 3rd quarter Group sales
14/09/2005Stallergènes: Excellent half year performance. Operating profit up 39%. Net profit up 58%
18/07/2005Stallergènes : 2005 1st Half-Year Group Sales Up 21%
14/04/2005Significant increase in 2005 1st quarter sales: + 21%
04/04/2005Project to buy back shares
18/03/20052004 Financial Year Results
